This marks the first live procedure at AAHS, as well as a first for Keenova. Treatment takes place over two days of annual meeting—injection on Wednesday and finger extension on Friday. Audience of ...
DUBLIN, Jan. 14, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that it will present a live treatment procedure with XIAFLEX ® (collagenase clostridium histolyticum) for Dupuytren's ...
DUBLIN - Keenova Therapeutics plc (trading at $64.64, up 0.9% from previous close) announced Tuesday that findings from a national survey on patient perceptions of Dupuytren’s contracture (DC) will be ...
DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX ® (collagenase clostridium histolyticum, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results